Lapachone Completed Phase 1 / 2 Trials for Malignancies Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00075933ARQ 501 in Subjects With Cancer